Sign inCreate Account
Ranbaxy Laboratories on Tuesday stood firm on its strategy of challenging patents, even as Pfizer has filed a suit against it to block the Gurgaon-based firm from going ahead with plans for Caduet.
NEWS
BUSINESS
MOVIES
CRICKET
SPORTS
GET AHEAD
REDIFF MONEY
REDIFF-TV
REDIFF ASTRO